Suppr超能文献

受大豆胰蛋白酶抑制剂、超速离心及辅助因子影响的血液凝血激酶的作用

Effect of blood thrombokinase, as influenced by soy bean trypsin inhibitor, ultracentrifugation, and accessory factors.

作者信息

MILSTONE J H

出版信息

J Gen Physiol. 1955 Jul 20;38(6):757-69. doi: 10.1085/jgp.38.6.757.

Abstract
  1. Crystallized soy bean trypsin inhibitor, at a concentration of 100 microg./ml., suppressed the production of thrombin from a mixture of prothrombin and blood thrombokinase. The experiment was performed in the presence of 0.011 M oxalate, in order to minimize the possibility of participation by accessory factors which require ionic calcium. The results are in accord with the view that thrombokinase is a trypsin-like enzyme. 2. When a solution of blood thrombokinase was centrifuged at 85,000 g for 120 minutes, almost all the activity remained in the supernate. This supernate activated the supernate from a prothrombin solution which had been similarly centrifuged. The activation of prothrombin by thrombokinase can proceed in the absence of material completely sedimentable in 120 minutes at 85,000 g. 3. An "accelerator" reagent was prepared by treating bovine serum with barium carbonate, and then passing the serum through a column of diatomaceous earth. This "accelerator" was used together with prothrombin, blood thrombokinase, Howell's cephalin, and calcium chloride to compose a five-reagent thrombin-producing system. In this system, no thrombin was produced without thrombokinase. On the other hand, thrombin was produced from prothrombin and thrombokinase, even when all the other reagents were omitted. When calcium was omitted, thrombokinase was able to function; but cephalin and the "accelerator" reagent were ineffective. 4. Quantitative tests indicated that the "accelerator" reagent exerted an effect distinct from those of thrombokinase and cephalin. However, it is not certain whether the "accelerator" reagent functioned as an accessory factor, as a potential source of more thrombokinase, or both. In the experiments reported, thrombokinase was primary to, or necessary for, the effect of "accelerator." 5. The effectiveness of thrombokinase was multiplied a hundred times or more, when complemented by calcium, cephalin, and "accelerator" reagent. Ionic calcium was a necessary component of this complementing system. This may help to explain why removal of calcium ions keeps blood fluid, even though thrombokinase, by itself, is little influenced either by calcium ions or by oxalate.
摘要
  1. 浓度为100微克/毫升的结晶大豆胰蛋白酶抑制剂抑制了凝血酶原与血液凝血激酶混合物中凝血酶的产生。实验在0.011M草酸盐存在的情况下进行,以尽量减少需要离子钙的辅助因子参与的可能性。结果与凝血激酶是一种胰蛋白酶样酶的观点一致。2. 当将血液凝血激酶溶液在85,000克离心120分钟时,几乎所有活性都保留在上清液中。这种上清液激活了经同样离心的凝血酶原溶液的上清液。凝血激酶对凝血酶原的激活可以在不存在在85,000克下120分钟内完全可沉淀物质的情况下进行。3. 通过用碳酸钡处理牛血清,然后使血清通过硅藻土柱制备了一种“加速剂”试剂。这种“加速剂”与凝血酶原、血液凝血激酶、豪厄尔脑磷脂和氯化钙一起用于组成一个五试剂凝血酶产生系统。在这个系统中,没有凝血激酶就不会产生凝血酶。另一方面,即使省略所有其他试剂,凝血酶也能从凝血酶原和凝血激酶中产生。当省略钙时,凝血激酶仍能发挥作用;但脑磷脂和“加速剂”试剂无效。4. 定量测试表明,“加速剂”试剂发挥了与凝血激酶和脑磷脂不同的作用。然而,尚不确定“加速剂”试剂是作为辅助因子发挥作用,作为更多凝血激酶的潜在来源,还是两者兼而有之。在所报道的实验中,凝血激酶对于“加速剂”的作用是首要的或必要的。5. 当由钙、脑磷脂和“加速剂”试剂补充时,凝血激酶的效力会增加一百倍或更多。离子钙是这种补充系统的必要成分。这可能有助于解释为什么去除钙离子能使血液保持液态,尽管凝血激酶本身很少受钙离子或草酸盐的影响。

相似文献

2
Preparation of thrombokinase from bovine plasma.
J Gen Physiol. 1959 Mar 20;42(4):665-76. doi: 10.1085/jgp.42.4.665.
3
OUTSTANDING CHARACTERISTICS OF THROMBOKINASE ISOLATED FROM BOVINE PLASMA.
J Gen Physiol. 1963 Nov;47(2):315-27. doi: 10.1085/jgp.47.2.315.
4
Thrombokinase of the blood as trypsin-like enzyme.
J Gen Physiol. 1962 Mar;45(4)Pt2(4):103-13. doi: 10.1085/jgp.45.4.103.
5
8
The effects of biguanides on thrombokinase, thrombin and trypsin.
Thromb Diath Haemorrh. 1975 Sep 30;34(1):246-55.
9
Prothrombin derivatives and the inhibition of thrombin formation with soy bean trypsin inhibitor.
Am J Physiol. 1955 Feb;180(2):367-70. doi: 10.1152/ajplegacy.1955.180.2.367.

本文引用的文献

2
Prothrombokinase and the Three Stages of Blood Coagulation.
Science. 1947 Dec 5;106(2762):546-7. doi: 10.1126/science.106.2762.546-a.
3
The anti-coagulants in blood and serum.
J Physiol. 1912 Sep 11;45(3):119-45. doi: 10.1113/jphysiol.1912.sp001541.
5
EFFECT OF BLOOD PROTEASE AND TRYPSIN INHIBITOR ON THE CLOTTING MECHANISM.
J Clin Invest. 1947 May;26(3):364-9. doi: 10.1172/JCI101818.
7
A highly active material that promotes conversion of prothrombokinase complex.
Proc Soc Exp Biol Med. 1949 Nov;72(2):315. doi: 10.3181/00379727-72-17419.
8
[Proconvertin].
Rev Hematol. 1952;7(2):147-55.
9
Proteolytic enzymes and platelets in relation to blood coagulation.
J Clin Invest. 1951 Jan;30(1):112-23. doi: 10.1172/JCI102411.
10
Chromatography of blood-clotting factors and serum proteins on columns of diatomaceous earth.
J Gen Physiol. 1955 Jul 20;38(6):743-55. doi: 10.1085/jgp.38.6.743.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验